Evidence map›Paper›PMID 25894343›Full record

ArticlePloS one2015

No viral association found in a set of differentiated vulvar intraepithelial neoplasia cases by human papillomavirus and pan-viral microarray testing.

Ozlen Saglam, Erik Samayoa, Sneha Somasekar, Samia Naccache, Akiko Iwasaki, Charles Y Chiu

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Ozlen SaglamDepartment of Pathology, Moffitt Cancer Center, Tampa, Florida, United States of America.
Erik SamayoaDepartment of Laboratory Medicine, University of California San Francisco, San Francisco, California, United States of America; UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, California, United States of America.
Sneha SomasekarDepartment of Laboratory Medicine, University of California San Francisco, San Francisco, California, United States of America; UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, California, United States of America.
Samia NaccacheDepartment of Laboratory Medicine, University of California San Francisco, San Francisco, California, United States of America; UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, California, United States of America.
Akiko IwasakiHoward Hughes Medical Institute, Department of Immunobiology, Yale University, New Haven, Connecticut, United States of America.
Charles Y ChiuDepartment of Laboratory Medicine, University of California San Francisco, San Francisco, California, United States of America; UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, California, United States of America; Department of Medicine, Division of Infectious Diseases, University of California San Francisco, San Francisco, California, United States of America.
Global Viral · USMoffitt Cancer Center · USUniversity of California, San Francisco · USYale University · US

Funding

Pan-Genomic Approaches for Comprehensive Blood Screening of Novel or Emerging Infectious AgentsR01HL105704 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHIU, CHARLES YEN · 2011 to 2020
$5.9M
Immunity to Genital Herpes Simplex-2R01AI054359 · NIAID · YALE UNIVERSITY · PI IWASAKI, AKIKO · 2004 to 2019
$5.2M
NHLBI NIH HHS HL105704NHLBI NIH HHS R01 HL105704NIAID NIH HHS R01 AI054359
6 · The paper itself

Abstract

Vulvar Intraepithelial Neoplasia (VIN) is the precursor lesion of Vulvar Squamous Cell Carcinoma (VSCC), and the differentiated type (dVIN) is more frequently observed in relation to VSCC. In contrast to usual-type VIN (uVIN), which is related to infection by human papillomavirus (HPV), a germline mutation in the p53 gene is thought to be associated with ~90% of dVIN cases. To date, no infectious agent has been identified in association with dVIN, and studies investigating this possibility have been hindered by the difficulty in accurately diagnosing dVIN from small biopsies. Here, we used immunostaining for p16ink4a), a biomarker for HPV infection, to study 14 uVIN high-grade VIN and 14 dVIN cases, and to select 10 dVIN cases to broadly screen for all kn(own viruses using a pan-viral microarray platform (ViroChip). All of the uVIN tissue samples, including 8 warty and 6 basaloid cases, showed positivity with the p16(ink4a) immunostain. The staining pattern was full-thickness for all except two cases in which positive staining was localized in the lower 1/3 of the epidermis. In contrast, immunostaining for p16(ink4a) was negative in all dVIN cases. ViroChip analysis of 10 pure dVIN samples confirmed the absence of human papillomavirus subtypes or any other virus with the exception of a single sample that showed a weak microarray signature to a porcine herpesvirus. Follow-up PCR testing of the sample was negative for herpesvirus, and in-depth metagenomic next-generation sequencing revealed only sequences corresponding to non-pathogenic viral flora and bacterial contamination. In this study, we demonstrated lack of a virus association in 10 dVIN cases. Alternative pathways for carcinogenesis such as the p53 mutation should be considered for investigation of potential treatment options in dVIN.

Indexed as

Oligonucleotide Array Sequence AnalysisAgedCarcinoma in SituCyclin-Dependent Kinase Inhibitor p16FemaleHigh-Throughput Nucleotide SequencingHumansMiddle AgedPapillomaviridaeVulvar NeoplasmsCyclin-Dependent Kinase Inhibitor p16

Identifiers

PMID25894343
PMCPMC4404153
OpenAlexW2323125593

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.